Background Human immunodeficiency virus (HIV) infection is the strongest risk factor for
developing tuberculosis and has fuelled its resurgence, especially in sub-Saharan Africa. In …

Background Global genetic diversity of HIV-1 is a major challenge to the development of HIV
vaccines. We aimed to estimate the regional and global distribution of HIV-1 subtypes and …

In 2005 women represented approximately half of all 190 million international migrants
worldwide. This paper addresses the need to integrate a gender perspective into …

Objective: To assess the degree of compliance with antiretroviral therapy in HIV-infected
patients, and identify which sociodemographic and psychological factors influence it, in …

Background: The incidence and severity of coronavirus disease 2019 (COVID-19) among
HIV-positive persons receiving antiretroviral therapy (ART) have not been characterized in …

Background. Some human immunodeficiency virus (HIV)–infected individuals initiating
combination antiretroviral therapy (cART) with low CD4 counts achieve viral suppression but …

Background: The barriers to HIV testing and counselling that migrants encounter can
jeopardize proactive HIV testing that relies on the fact that HIV testing must be linked to care …

Background. Recent updates of human immunodeficiency virus (HIV) treatment guidelines
have raised the CD4+ cell count thresholds for antiretroviral therapy initiation from 350 to …

Health systems have improved their abilities to identify, diagnose, treat and, increasingly,
achieve viral suppression among people living with HIV (PLHIV). Despite these advances, a …

Background. Human immunodeficiency virus type 1 (HIV-1) subtype may influence disease
progression. We compared CD4 lymphocyte cell count levels at seroconversion, decline …